Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth Initiative’s (WTI) work at the HOPE Field Hospital in the Kutupalong Refugee Camp in Bangladesh.
Novartis’ Ligelizumab (QGE031) Receives the US FDA’s Breakthrough Designation for Patients with Chronic Spontaneous Urticaria Published: Jan 15, 2020 | Tags: Novartis’, Ligelizumab (QGE031), Receives ,US FDA’s, Breakthrough Designation for Patients , Chronic Spontaneous Urticaria Philips Collaborates with Merck KGaA to Advance Personalized Fertility Treatment… Read More »PharmaShots Weekly Snapshots (Jan 11 – 15, 2021)
Shots: The companies reported that joint Livongo for diabetes and dexcom members will now receive CGM-powered insights that enables members to easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels In Oct’2020, Teldoc merges with Livongo while in Jan’2020… Read More »Teladoc Health and Dexcom Offers CGM-Powered Insight for T2D
Six competitor CEOs and one ex-CMO discuss the biggest-ever digital health merger by JESS DAMASSA & MATTHEW HOLT It was the news that stunned the world of health tech. And us! So we had seven of Teladoc and Livongo’s biggest competitors weigh-in on what the… Read More »Teladoc & Livongo — The Health Techerati Weigh-In